1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Dermatologicals in Colombia

Dermatologicals in Colombia

  • September 2016
  • -
  • Euromonitor International
  • -
  • 32 pages

In Colombia, consumer awareness of the availability of OTC dermatologicals to treat common problems, mainly those related to fungus conditions, increased rapidly over the review period. Advertising played an important role, and contributed to increasing the share of antifungals, which accounted for a 41% share of value sales of dermatologicals in 2016; five percentage points more than at the beginning of the review period.

Euromonitor International’s Dermatologicals in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Dermatologicals in Colombia
DERMATOLOGICALS IN COLOMBIA
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2011-2016
Table 2 Sales of Dermatologicals by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Dermatologicals: % Value 2012-2016
Table 4 LBN Brand Shares of Dermatologicals: % Value 2013-2016
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2013-2016
Table 6 Forecast Sales of Dermatologicals by Category: Value 2016-2021
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2016-2021
GlaxoSmithKline Colombia SA in Consumer Health (colombia)
Strategic Direction
Key Facts
Summary 1 GlaxoSmithKline Colombia SA: Key Facts
Summary 2 GlaxoSmithKline Colombia SA: Operational Indicators
Competitive Positioning
Summary 3 GlaxoSmithKline Colombia SA: Competitive Position 2016
Jgb Sa, Laboratorios in Consumer Health (colombia)
Strategic Direction
Key Facts
Summary 4 Laboratorios JGB SA: Key Facts
Summary 5 Laboratorios JGB SA: Operational Indicators
Competitive Positioning
Summary 6 Laboratorios JGB SA: Competitive Position 2016
Laboratorios La Sante SA in Consumer Health (colombia)
Strategic Direction
Key Facts
Summary 7 Laboratorios La Sante SA: Key Facts
Summary 8 Laboratorios La Sante SA: Operational Indicators
Competitive Positioning
Summary 9 Laboratorios La Sante SA: Competitive Position 2016
Tecnoquímicas SA in Consumer Health (colombia)
Strategic Direction
Key Facts
Summary 10 Tecnoquímicas SA: Key Facts
Summary 11 Tecnoquímicas SA: Operational Indicators
Competitive Positioning
Summary 12 Tecnoquímicas SA: Competitive Position 2016
Executive Summary
Consumer Health Sees A Positive Performance
the Authorities Watch Advertising More Closely
Foreign Companies Dominate the Landscape
Chemists/pharmacies Remains the Leading Distribution Channel in Consumer Health
Positive Outlook for Consumer Health
Key Trends and Developments
Increasing Vigilance From the Authorities on Controversial Products
Colombian Population in the Quest for Healthy Ageing
Further Efforts To Spread A Responsible Self-medication Culture in Colombia
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 13 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

OTC Industry in the US

  • March 2017
    89 pages
  • OTC  

  • United States  

View report >

OTC Industry in New Caledonia

  • March 2017
    9 pages
  • OTC  

  • New Caledonia  

View report >

Otc Supply In The Us

17 days ago

Otc Markets In Europe

25 days ago

Related Market Segments :

OTC
Acne Treatment

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.